What’s next after OCM?
The end of the Oncology Care Model (OCM) is fast approaching, but there remains uncertainty about what comes next. Panelists speculated that the successor model will address the high cost of cancer drugs and will likely be mandatory.
Social determinants of health are crucial to improving outcomes
Improvements in cancer treatment are not benefitting all patients equally and understanding social determinants of health is crucial to improving outcomes, said Karen Winkfield, MD, PhD, of Meharry-Vanderbilt Alliance, during the opening session.
Targeted interventions may predict health behaviors
Targeting interventions to patients will mean understanding patients beyond just their health. Robert Groves, MD, of Banner | Aetna, explained that data sets can help predict health behaviors of populations..
Telemedicine is here to stay
Telemedicine use increased during the pandemic out of necessity, and it isn’t going away. The COVID-19 pandemic created a surge in the use of technology and telemedicine that will allow providers to deliver better care.
Oncology care navigation: A game changer
The patient journey in cancer treatment is never easy, but the rise of care navigation has been a game changer for patient satisfaction and better outcomes. However, despite the benefits, reimbursement can be elusive.
Oncology care navigation: A game changer
The patient journey in cancer treatment is never easy, but the rise of care navigation has been a game changer for patient satisfaction and better outcomes. However, despite the benefits, reimbursement can be elusive.
CO-CHAIR, Vice President of Government Affairs and Senior Medical Director for Employer Strategy
CO-CHAIR, Vice President of Government Affairs and Senior Medical Director for Employer Strategy
KEYNOTE SPEAKER, Vice President of Government Affairs and Senior Medical Director for Employer Strategy
STEERING COMMITTEE, Vice President, CMO, Cardinal Health Specialty Solutions, Alberta, GA
STEERING COMMITTEE, President and Managing Physician, Florida Cancer Specialists, Gainesville, FL
STEERING COMMITTEE, President & CEO, Regional Cancer Care Associates, Hackensack, NJ
STEERING COMMITTEE, Attorney & Founding Partner, Frier Levitt Pine, Brook, NJ
Partner, Farragut Partners, Washington, DC
STEERING COMMITTEE, Dell Medical School of the University of Texas at Austin Texas Oncology, Austin, TX
STEERING COMMITTEE, CEO, OneOncology Tennessee Oncology, Nashville, TN
STEERING COMMITTEE, Executive Director, Meharry-Vanderbilt Alliance Vanderbilt University Medical Center, Nashville, TN
- AccessHope
- American Oncology Network
- Anthem
- Atlantic Health
- Banner | Aetna
- BlueCross BlueShield
- Cardinal Health
- Centers for Medicare & Medicaid Services
- City of Hope
- Community Oncology Alliance
- Emory Healthcare
- Florida Cancer Specialists
- Highmark
- Humana
- Intermountain Healthcare
- Kaiser Permanente
- Magellan Health
- McKesson
- MD Anderson Cancer Center
- Memorial Sloan Kettering Cancer Center
- Montefiore Medical Center
- Moffitt Cancer Center
- OneOncology
- Optum
- Penn Medicine
- Penn State Cancer Institute
- Penn State University
- Pontchartrain Cancer Center
- Quality Cancer Care Alliance
- Regional Cancer Care Associates
- Tennessee Oncology
- Texas Oncology
- UCLA
- University of Pittsburgh Medical Center
- US Oncology Network
- Vanderbilt University Medical Center